TGTX — TG Therapeutics, Inc. stock price, charts and financials

QT80TG Therapeutics, Inc.

TG Therapeutics, Inc. (NASDAQ: TGTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
48.74
+2.57+5.57%
OverviewShort InterestFilings
TGTXQT80TG Therapeutics, Inc.·NASDAQ
48.74+5.57%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 20268-KCurrent report
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 03, 20268-KCurrent report
May 27, 20268-KCurrent report
May 06, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 20, 20268-KCurrent report
Feb 27, 202610-KAnnual report
Feb 26, 20268-KCurrent report
Jan 29, 20264Statement of changes in beneficial ownership
Jan 13, 20268-KCurrent report
Jan 09, 20264Statement of changes in beneficial ownership
Jan 09, 20264Statement of changes in beneficial ownership
Nov 25, 20254Statement of changes in beneficial ownership
Nov 10, 2025SC 13GBeneficial ownership statement (passive)
Nov 07, 20254Statement of changes in beneficial ownership
Nov 05, 202510-QQuarterly report
#1 / 25 of 162
Page
▼
/ 7